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author and source are credited.Special feature on evolution and genetics
in medicine
Brian G. Spratt and Roy M. Anderson
Department of Infectious Disease Epidemiology, Imperial College London, London, UKThe origins of genetics and evolution are relatively recent in the context of the 350
years of scientific publication that are celebrated this year by the Royal Society,
emerging in the 1850s and 1860s with the work of Gregor Mendel and Charles
Darwin. The rediscovery of Mendel’s laws of inheritance in 1900, and the dem-
onstration by Garrod [1] in 1902 that they could explain the familial distribution
of alkaptonuria, was perhaps the first contribution of genetics to medicine.
Important work in the 1920s and 1930s by Haldane, Fisher and Wright on
the development of population genetics and, subsequently, the formulation of
the modern evolutionary synthesis provided the basis of our current understand-
ing of population and evolutionary biology. Haldane was also probably the first
to introduce an evolutionary perspective into medicine, suggesting in 1949 that
selection for resistance to malaria might explain the high levels of thalassaemia
in malarious regions [2].
However, the discoveries that led most directly to the remarkable recent
progress in genetic and evolutionary approaches in medicine go back to the
1940s and 1950s with the establishment of DNA as the genetic material and
the elucidation of its structure, with the subsequent emergence of molecular
biology in the following decade.
An important recent stimulus to research on genetics and evolution in medi-
cinewas the sequencing of the human genome.On 26 June 2000, the International
Human Genome Sequencing Consortium announced the production of a rough
draft of the human genome sequence. In April 2003, the Consortium announced
an essentially finished version of the human genome sequence. This version,
which is available to the public, provided nearly all the information needed to
research almost all aspects of the whole genome. The initial promise of this
achievement, for rapid progress in understanding the genetic basis of many
common human diseases, was slow to be realized given the polygenic nature
of the susceptibility of individuals to most of these conditions.
However, in recent years, progress has been steady, due to new methods for
rapid and low-cost sequencing of multiple genomes, combined with advances
in bioinformatics and new statistical tools that permit the identification of com-
plex multi-genic associations between host genetic background and the
likelihood of a particular disease occurring. Concomitant with advances in
the study of the human genome has been the complete sequencing of all the
major pathogens of humans, and the use of these sequences to address a
wide range of problems, including defining ‘who infects whom’, and what gen-
etic factors control pathogenicity and transmissibility. Complete sequences for
the human host and a particular infectious agent have revealed the complex
interplay between the two genetic templates in all host–parasite associations
in determining the course of infection and associated morbidity and mortality.
In this issue of the Proceedings of the Royal Society B: Biological Sciences, six
contributions are presented that chart past and present progress in a series of
important fields where genetic and evolutionary research have made important
contributions to a variety of areas in medicine. The areas covered are not
exhaustive of the fields where such research has made important contributions
to current medical practice and the treatment of disease. For example, one very
important area not covered in this issue is cancer research, where the ability to
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having both a major clinical impact and an impact on the
design and testing of new small molecule or immunothera-
peutic treatments. However, the contributions in this issue
provide an exciting reflection of current genetic and evol-
utionary research, which is advancing our understanding of
the causes and treatment of disease and infection.
Current progress in genome-wide association studies
between genetic polymorphisms and commongenetic disorders
is reviewed by Donnelly and co-workers [3]. Technological
advances have allowed the detection of genome-wide genetic
variation in large population cohorts, which, combined with
sophisticated statistical analyses, are allowing the identification
of variants associatedwith susceptibility to common genetic dis-
eases. These studies provide the identification of genes and
pathways that may lead to a better understanding of these
diseases as well as new approaches to treatment.
Collins & Thrasher [4] review progress in gene therapy,
another area that has been a focus of much recent research,
although progress has been relatively slow. However, new
approaches, including the ability to precisely correct genetic
defects—gene editing—promise major advances in gene
therapy, although ethical concerns still have to be addressed.
The origins of immunology can be traced back to at least
the early eighteenth century, but studies during the last 60
years have provided a detailed picture of the complex sys-
tems that have evolved to protect against disease. Thearticle by McMichael and co-workers [5] focuses on what is
known about the development and decline of the human
immune system from birth to old age, and the consequences
for protection against infection and for autoimmunity
and malignancy.
Cardiovascular diseases remain a major cause of morbidity
and mortality throughout the world, and Kennedy-Lydon &
Rosenthal [6] discuss the prospects for cardiac regeneration
to repair the damage resulting from mycocardial infarction.
A very different area where large-scale genome sequen-
cing is having an impact is in the study of pathogens,
where sophisticated analytical tools that combine the
genome sequences of large samples of pathogen isolates
with geospatial and temporal data are leading to an under-
standing of the origins, evolution, pathogenicity and
epidemiology of viral and bacterial diseases, with the pro-
spect of greatly improved real-time surveillance of disease
outbreaks. Pybus et al. [7] and Bentley & Parkhill [8], respect-
ively, describe recent progress in this area for viral and
bacterial pathogens.
We hope this selection of contributionswill serve as a stimu-
lus for expanded research in this fascinating field that combines
old (but fundamental) concepts such as the theory of evolution
by natural selection, with new technologies in whole-genome
sequencing andmolecular biology that are beginning to unravel
the detailed mechanisms of disease causation and highlight
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